Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

dc.contributor.authorKilickap, S.
dc.contributor.authorOzturk, A.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYumuk, P.
dc.contributor.authorCicin, I.
dc.contributor.authorPaydas, S.
dc.date.accessioned2024-02-23T14:49:10Z
dc.date.available2024-02-23T14:49:10Z
dc.date.issued2018
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.endpageS478en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageS477en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/18035
dc.identifier.volume13en_US
dc.identifier.wosWOS:000454014501235en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal Of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNsclcen_US
dc.subjectAlk Inhibitoren_US
dc.subjectCrizotiniben_US
dc.titleCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkeyen_US
dc.typeConference Objecten_US

Dosyalar